Oruka Therapeutics (ORKA) Misses Q4 EPS by 49c
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics (NASDAQ: ORKA) reported Q4 EPS of ($0.49).
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Pony AI (PONY) call put ratio 1 call to 1 put into quarter results
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
